GSK — GLAXOSMITHKLINE PLC

Ownership history in Engineers Gate Manager LP  ·  16 quarters on record

This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in GLAXOSMITHKLINE PLC (GSK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2022 Q3)
Avg. % of fund
0.03%
First filed
2019 Q4
Last filed
2025 Q3
Quarters held
16
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 58,422 +33,349 +133.0% 0.03% $2.5M $42.44
2025 Q2 REDUCED 25,073 -6,500 -20.6% 0.01% $963K $37.35
2025 Q1 REDUCED 31,573 -10,074 -24.2% 0.02% $1.2M $37.25
2024 Q4 REDUCED 41,647 -16,820 -28.8% 0.02% $1.4M $32.17
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    GSK price (monthly, adj. close)

Other funds also holding GSK

As of 2025 Q4 — sorted by position size

Eversept Partners, LP 3Y 7Y 6.62% Mondrian Investment Partners LTD 3Y 7Y 4.7% EQUITY INVESTMENT CORP 3Y 7Y 4.07% Callodine Capital Management, LP 3Y 7Y 3.96% Hillman Capital Management, Inc. 3Y 7Y 3.53% KEATING INVESTMENT COUNSELORS INC 3Y 7Y 2.45% MILLER HOWARD INVESTMENTS INC /NY 3Y 7Y 2.43% Clean Yield Group 3Y 7Y 2.2% NIA IMPACT ADVISORS, LLC 3Y 2.08% Altrius Capital Management Inc 3Y 2.05%
← Back to Engineers Gate Manager LP Holdings